What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
CIK: 0001801265
Total reported value
$2.3B
$2.3B
15 檔
28.0%
In Q4 2024, Madison Avenue Partners, LP's U.S. equity holdings reached a combined market value of $2.3B, distributed across 15 disclosed stock positions.
In Q4 2024, Madison Avenue Partners, LP adopted a defensive or profit-taking posture, trimming 5 positions and completely liquidating 12 holdings to manage risk exposure.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | GHC | Graham Holdings Co-class B | Stock-Industrials | 21.72% | +0.81% | — | |
| 2 | SOLV | Solventum CORP | Stock-Healthcare | 19.78% | +0.45% | — | |
| 3 | WLY | Wiley (john) & Sons-class A | Stock-Other | 9.70% | -1.12% | EXIT | |
| 4 | TBPH | Theravance Biopharma, Inc. | Stock-Other | 9.48% | +0.03% | — | |
| 5 | ACHC | Acadia Healthcare Co Inc | Stock-Other | 8.08% | — | — | |
| 6 | 0C3 | Endeavor Group Hold-class A | Stock-Other | 7.94% | — | +228.33% | |
| 7 | MAGN | Magnera CORP | Stock-Other | 6.55% | — | — | |
| 8 | STGW | Stagwell Inc | Stock-Other | 4.98% | +0.37% | — | |
| 9 | INDV | Indivior Pharmaceuticals, Inc. | Stock-Other | 4.84% | — | -7.25% | |
| 10 | NNI | Nelnet Inc-cl A | Stock-Other | 3.28% | — | — | |
| 11 | INVX | Innovex International Inc | Stock-Other | 2.49% | — | +64.62% | |
| 12 | FSP | Franklin Street Properties C | Stock-Other | 0.53% | -0.03% | EXIT | |
| 13 | OVID | Ovid Therapeutics Inc | Stock-Other | 0.37% | — | -9.57% | |
| 14 | TSVT* | 2seventy Bio Inc | Stock-Other | 0.18% | — | -77.38% | |
| 15 | SN | SharkNinja, Inc. | Stock-Consumer Disc | 0.06% | -0.03% | EXIT |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | ACHC | Acadia Healthcare Co Inc | +8.1% | NEW | New buy |
| 2 | MAGN | Magnera CORP | +6.6% | NEW | New buy |
| 3 | 0C3 | Endeavor Group Hold-class A | +6% | +228.33% | Add |
| 4 | GHC | Graham Holdings Co-class B | +3.8% | — | Unchanged |
| 5 | TBPH | Theravance Biopharma, Inc. | +2.4% | — | Unchanged |
| 6 | SOLV | Solventum CORP | +1.5% | — | Unchanged |
| 7 | INDV | Indivior Pharmaceuticals, Inc. | +1.3% | -7.25% | Trim |
| 8 | INVX | Innovex International Inc | +1.1% | +64.62% | Add |
| 9 | STGW | Stagwell Inc | +0.3% | — | Unchanged |
| 10 | NNI | Nelnet Inc-cl A | +0.2% | — | Unchanged |
| 11 | SN | SharkNinja, Inc. | — | — | Unchanged |
| 12 | ZIMV | Zimvie Inc | — | EXIT | Sold out |
| 13 | FSP | Franklin Street Properties C | 0% | -16.95% | Trim |
| 14 | TALK | Talkspace Inc | -0.1% | EXIT | Sold out |
| 15 | OVID | Ovid Therapeutics Inc | -0.1% | -9.57% | Trim |
| 16 | CEE | Central And Eastern Europe F | -0.1% | EXIT | Sold out |
| 17 | NWS | News CORP - Class B | -0.1% | EXIT | Sold out |
| 18 | MODVQ | Modivcare Inc | -0.4% | EXIT | Sold out |
| 19 | WLY | Wiley (john) & Sons-class A | -0.6% | -8.45% | Trim |
| 20 | RVNCEUR | Revance Therapeutics Inc | -0.7% | EXIT | Sold out |
| 21 | TSVT* | 2seventy Bio Inc | -0.9% | -77.38% | Trim |
| 22 | AMTM | Amentum Holdings Inc | -1% | EXIT | Sold out |
| 23 | NWSA | News CORP - Class A | -1.1% | EXIT | Sold out |
| 24 | DCO | Ducommun Inc | -2.2% | EXIT | Sold out |
| 25 | QDEL | Quidelortho CORP | -4.4% | EXIT | Sold out |
| 26 | GMED | Globus Medical Inc - A | -7.5% | EXIT | Sold out |
| 27 | LBRDK | Liberty Broadband-c | -12.2% | EXIT | Sold out |
According to official SEC Form 13F filings, Madison Avenue Partners, LP reported a total U.S. public equity portfolio value of $2.3B across 15 disclosed positions in Q4 2024.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including GHC, SOLV, WLY) accounted for 28.0% of total reported equity market value during Q4 2024.
Top New Position Initiated
ACHC
市值: $76.3M
Top Position Liquidated / Trimmed
LBRDK
前期市值: $131.1M
During Q4 2024, Madison Avenue Partners, LP's top holdings by market value included GHC (21.7%)、SOLV (19.8%)、WLY (9.7%). The largest single position, GHC, represented 21.7% of total portfolio value.
In Q4 2024, Madison Avenue Partners, LP made 21 total portfolio adjustments, initiating 2 new buys, adding to 2 positions, trimming 5 holdings, and fully liquidating 12 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.